Literature DB >> 4468198

C3 proactivator (C3PA) as an acute phase reactant.

M Schutte, R DiCamelli, P Murphy, M Sadove, H Gewurz.   

Abstract

Mesh：

Substances：

Year:  1974        PMID： 4468198      PMCID： PMC1537887     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  21 in total

1.  Serologic tests for inflammation; serum complement, c-reactive protein and erythrocyte sedimentation rate in myocardial infarction.

Authors:  A J BOLTAX; E E FISCHEL
Journal:  Am J Med       Date:  1956-03       Impact factor: 4.965

2.  Immunochemical quantitation of the third, fourth and fifth components of human complement: concentrations in the serum of healthy adults.

Authors:  P F Kohler; H J Müller-Eberhard
Journal:  J Immunol       Date:  1967-12       Impact factor: 5.422

3.  The C3-activator system: an alternate pathway of complement activation.

Authors:  O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

4.  Sequential changes of plasma proteins after myocardial infarction.

Authors:  B G Johansson; C O Kindmark; E Y Trell; F A Wollheim
Journal:  Scand J Clin Lab Invest Suppl       Date:  1972

5.  Time sequence of acute phase reactive proteins following surgical trauma.

Authors:  R A Crockson; C J Payne; A P Ratcliff; J F Soothill
Journal:  Clin Chim Acta       Date:  1966-10       Impact factor: 3.786

6.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

7.  Isolation and properties of a glycine-rich beta-glycoprotein of human serum.

Authors:  T Boenisch; C A Alper
Journal:  Biochim Biophys Acta       Date:  1970-12-22

8.  Immunochemical quantitation of human Cl esterase (Cls): concentration in normal serum and purification yields.

Authors:  K Nagaki; R M Stroud
Journal:  J Immunol       Date:  1970-07       Impact factor: 5.422

9.  Cobra venom-induced hemolysis. Activity levels in sera of patients with neoplastic and other diseases.

Authors:  M Brai; A G Osler
Journal:  J Exp Med       Date:  1972-10-01       Impact factor: 14.307

10.  C3 proactivator convertase and its mode of action.

Authors:  H J Müller-Eberhard; O Götze
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307
View more
  15 in total

1.  Complement levels in pneumococcal pneumonia.

Authors:  J D Coonrod; B Rylko-Bauer
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

2.  Alternative complement pathway activity in sera from patients with sickle cell disease.

Authors:  S M Koethe; J T Casper; G E Rodey
Journal:  Clin Exp Immunol       Date:  1976-01       Impact factor: 4.330

3.  The complement profile in relation to the "reactor" state: a study in the immediate post-partum period.

Authors:  L W Mak
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

4.  Correlations between serum factor B and C3b inactivator levels in normal subjects and in patients with infections, nephrosis and hypocomplementaemic glomerulonephritis.

Authors:  J Forristal; K Iitaka; E H Vallota; C D West
Journal:  Clin Exp Immunol       Date:  1977-04       Impact factor: 4.330

5.  Correlation of serum opsonins with in vitro phagocytosis of Streptococcus pneumoniae.

Authors:  D S Chudwin; S G Artrip; A Korenblit; G Schiffman; S Rao
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

6.  C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.

Authors:  K Whaley; P H Schur; S Ruddy
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

7.  Circulating immune complexes in sera of children with neuroblastoma: correlation with stage of disease.

Authors:  W E Brandeis; L Helson; Y Wang; R A Good; N K Day
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

8.  Five new rare variants of the properdin factor B (BF) locus.

Authors:  D D Dykes; C M DeFurio; H F Polesky
Journal:  Am J Hum Genet       Date:  1983-07       Impact factor: 11.025

9.  Activation of the alternate complement pathway in Staph. aureus infective endocarditis and its relationship to thrombocytopenia, coagulation abnormalities, and acute glomerulonephritis.

Authors:  D T O'Connor; M H Weisman; J Fierer
Journal:  Clin Exp Immunol       Date:  1978-11       Impact factor: 4.330

10.  Complement system in pneumococcal infections.

Authors:  W P Reed; M S Davidson; R C Williams
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.